Platelet-activating factor stimulates lung pericyte growth in vitro

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 2 14-2, 1996, Pages

  Khoury, Joseph ^a   Langleben, David ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

adult respiratory distress syndrome; cytokine; lung injury; pulmonary hypertension; vascular remodeling

Indexed keywords

CYTOKINE; THROMBOCYTE ACTIVATING FACTOR; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LUNG BLOOD VESSEL; MALE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0029867369     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.2.l298     Document Type: Article

References (45)

1. Benveniste, J. Paf-Acether, an ether phospho-lipid with biological activity. Prog. Clin. Biol. Res. 282: 73-85, 1988.
2. Benveniste, J.,P. M.Henson, and C. G. Cochrane. Leukocyte-dependent histamine release from rabbit platelets. J. Exp. Med. 136: 1356-1377, 1972.
3. Benveniste, J., J. P. LeCouedic, J. Polonsky, and M. Tence, Structural analysis of purified platelet-activating factor by lipases. Nature Lond. 269: 170-171, 1977.
4. Bone, R. C. Phospholipids and their inhibitors: a critical evaluation of teir role in the treatment of sepsis. Crit. Care Med. 20: 884-890, 1992.
5. Braquet, P., and D. Hosford. The potential role of platelet activating factor (PAF) in shock, sepsis, and adult respiratory distress syndrome (ARDS). Prog. Clin. Biol. Res. 308: 425-439, 1989.
6. Bussolino, F., F. Silvagno, G. Garbarino, C. Costamagna, F. Sanavio, M. Arese, R. Soldi, M. Aglietta, G. Pescarmona, G. Camussi, and A. Bosia. Human endothelial cells are targets for platelet-activating factor (PAF). J. Biol. Chem. 269: 2877-2886, 1994.
7. Camussi, G., M. Aglietta, F. Malavasi, C. Tetta, W. Piacibello, F. Sanavio, and F. Bussolino. The release of platelet-activating factor from human endothelial cells in culture. J. Immunol. 131: 2397-2403, 1983.
8. Chang, S. W. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils. Clin. Res. 40: 528-535, 1992.
9. Chang, S. W., C. O. Fedderson, P. M. Henson, and N. F. Voelkel. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin treated rats. J. Clin. Invest. 79: 1498-1509, 1987.
10. Christman, B. W., P. L. Lefferts, I. A. Blair, and J. R. Snapper. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep. Am. Rev. Respir. Dis. 142: 1272-1278, 1990.
11. Davies, P., B. T. Smith, F. B. Maddalo, D. Langleben, D. Tobias, K. Fujiwara, and L. Reid. Characteristics of lung pericytes in culture including their growth inhibition by endothelial substrate. Microvasc. Res. 33: 300-314, 1987.
12. Demopoulos, C. A., R. N. Pinckard, and D. J. Hanahan. Platelet activating factor: evidence for 1-O-alkyl-2-acetyl-sreglyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254: 9355-9358, 1979.
13. Evangelou, A. M. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukotrienes Essent. Fatty Acids 50: 1-28, 1994.
14. Facchinetti, A., L. Tessarollo, M. Mazzocchi, R. Kingston, D. Collavo, and G. Biasi. An improved method for the detection of DNA fragmentation. J. Immunol. Methods 136: 125-131, 1991.
15. Fink, A., D. Geva, A. Zung, S. Konichezky, A. Eliraz, and Z. Bentwich. Adult respiratory distress syndrome: roles of leukotriene C4 and platelet activating factor. Crit. Care Med. 18: 905-910, 1990.
16. Gillespie, M. N., and B. D. Bowdy. Impact of platelet activating factor on vascular responsiveness in isolated rat lungs. J. Pharmacol. Exp. Ther. 236: 396-402, 1986.
17. Gitlin, J. D., and P. A. D'Amore. Culture of retinal capillary cells using selective growth media. Microvasc. Res. 26: 74-80, 1979.
18. Haynes, J., S. W. Chang, K. G. Morris, and N. F. Voelkel. Platelet activating factor antagonists increase vascular reactivity in perfused rat lungs. J. Appl. Physiol. 65: 1921-1928, 1988.
19. Henson, P. M. PAF-a perspective. Am. J. Respir. Cell Mol. Biol. 1. 263-265, 1989.
20. Jackson, E. M., G. E. Mott, C. Hoppens, L. M. McManus, S. T. Weintraub, J. C. Ludwig, and R. N. Pinckard. High performance liquid chromatography of platelet-activating factors. J. Lipid Res. 25: 753-757, 1984.
21. Jones, R., D. Langleben, and L. M. Reid. Patterns of remodelling of the pulmonary circulation in acute and subacute lung injury. In: The Pulmonary Circulation and Acute Lung Injury, edited by S. I. Said. Mount Kisco, NY: Futura, 1991, p. 179-242.
22. Knedler, A., and R. G. Ham. Optimized medium for clonal growth of human microvascular endothelial cells with minimal medium. In Vitro 23: 481-491, 1987.
23. 22a. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
24. Lynch, J. M., and P. M. Henson. The intracellular retention of newly synthesized platelet-activating factor. J. Immunol. 137: 2553-2656, 1986.
25. McIntyre, T. M., G. A. Zimmerman, and S. M. Prescott. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl. Acad. Sci. USA 83: 2204-2208, 1986.
26. McIntyre, T. M., G. A. Zimmerman, K. Satoh, and S. M. Prescott. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J. Clin. Invest. 76: 271-280, 1985.
27. McManus, L. M., and R. N. Pinckard. Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. Am. J. Pathol. 121: 55-68, 1985.
28. McManus, L. M., D. S. Woodard, S. I. Deavers, and R. N. Pinckard. PAF molecular heterogeneity: pathobiological implications. Lab. Invest. 69: 639-650, 1993.
29. McMurtry, I. F., and K. G. Morris. Platelet-activating factor causes pulmonary vasodilation in the rat. Am. Rev. Respir. Dis. 134: 757-762, 1986.
30. Montero, A., A. Rodriguez-Barbero, and J. M. Lopez-Novoa. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. Eur. J. Pharmcol. 243: 235-240, 1993.
31. Ohar, J. A., J. A. Pyle, K. S. Waller, T. M. Hyers, R. O. Webster, and D. Lagunoff. A rabbit model of pulmonary hypertension induced by the synthetic platelet activating factor acetylglyceryl ether phosphorylcholine. Am. Rev. Respir. Dis. 141: 104-110, 1990.
32. Ohar, J. A., K. S. Waller, and T. E. Dahms. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs. Am. Rev. Respir. Dis. 148: 158-163, 1993.
33. Ohar, J. A., K. S. Waller, D. DeMello, and D. Lagunoff. Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits. Lab. Invest. 65: 451-458, 1991.
34. Ohar, J.A., K. S. Waller, J. Pantano, D. E. DeMello, and T. E. Dahms. Chronic platelet-activating factor induces a decrease in pulmonary vascular compliance, hydroxyproline, and loss of vascular matrix. Am. J. Respir. Crit. Care Med. 149: 1628-1634, 1994.
35. Ono, S., and N. F. Voelkel. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J. Appl. Physiol 71: 2483-2492, 1991.
36. Ono, S. and N. F. Voelkel. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. Lung 170: 31-40, 1992.
37. Pinckard, R. N., E. M. Jackson, C. Hoppens, S. T. Weintraub, J. C. Ludwig, L. M. McManus, and G. E. Mott. Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 122: 325-332, 1984.
38. Prescott, S. M., T. M. McIntyre, and G. A. Zimmerman. The role of platelet-activating factor in endothelial cells. Thromb. Hemost. 64: 99-103, 1990.
39. Rabinovici, R., T. L.Yue, J. Vernick, and G. Feuerstein. PAF and TNF interactions in the pathophysiology of septic shock. In: Cell-Cell Interactions in the Release of Inflammatory Mediators, edited by P. Y. K. Wong and C. N. Serhan. New York: Plenum, 1991, p 193-203.
40. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular cloning. In: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989, p. 6.3-6.62.
41. Stoll, L. L., and A. A. Spector. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture. J. Cell. Physiol. 139: 253-261, 1989.
42. Tomashefski, J. F., P. Davies, C. Boggis, R. Greene, W. M. Zapol, and L. M. Reid. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am. J. Pathol. 112: 112-126, 1983.
43. Whatlet, R. E., S. M. Prescott, T. M. McIntyre, and G. A. Zimmerman. In situ and isolated pulmonary vascular cells produce platelet-activating factor when stimulated by bradykinin or calcium ionophore (Abstract). Clin. Res. 34: 586A, 1986.
44. Zapol, W. M., and M. T. Snider. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296: 476-480, 1977.
45. Zimmerman, G. A., T. M. McIntyre, and S. M. Prescott. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 76: 2235-2246, 1985.